Liquid Biopsy Assays

About Agena Bioscience

Agena Bioscience is a provider of targeted genomic analysis solutions, centered on its proprietary MassARRAY System which combines PCR with MALDI-TOF mass spectrometry. The company serves the research and clinical diagnostics markets with a focus on pharmacogenetics, oncology mutation profiling, hereditary genetics, and sample integrity testing. As a division of Mesa Labs, Agena operates globally with a business model based on selling instruments, consumable assays, and related services to molecular laboratories.

About Qiagen

Founded in 1984, QIAGEN has established itself as a foundational player in the life sciences tools and molecular diagnostics sector with a mission to 'make improvements in life possible.' The company's strategy is built on its integrated 'Sample to Insight' workflow solutions, serving diverse end markets from clinical diagnostics to pharmaceutical R&D. With a market cap of $8.13B and a broad portfolio, QIAGEN leverages its scale and technological breadth to drive growth in areas like digital PCR, next-generation sequencing (NGS), and syndromic testing.

Therapeutic Areas